Literature DB >> 29382243

Development of an exercise intervention as part of rehabilitation in a glioblastoma multiforme survivor during irradiation treatment: a case report.

Anders Hansen1,2, Karen Søgaard1,3, Lisbeth Rosenbek Minet4,5.   

Abstract

INTRODUCTION: This case report describes the rationale and development of an exercise intervention in a patient with glioblastoma multiforme (GBM ) and discusses potential relations of observed effects in functional performance and quality of life (QOL).
METHODS: A 54-year-old GBM survivor completed a supervised six-week exercise intervention during irradiation treatment beginning 42 d after resection. Exercise modalities of cardiorespiratory, resistance, and balance training were designed on generic recommendations of various cancer populations and literature review.
RESULTS: Our case attended all possible sessions without experiencing adverse effects, and improved in aerobe power (24%), muscle strength (0-38%), standing balance (71%), walking ability (9%), and QOL domains of "Global Health Status/QoL" and "Physical functioning."
CONCLUSIONS: Based on this single case, exercise rehabilitation has the ability to maintain or improve functional performance and QOL domains even during heavy treatments. It also implies that patients with GBM are capable and may be willing to participate in exercise rehabilitation if supervised by physical therapists. Implications for rehabilitation The use of exercise as part of rehabilitation still needs attention in strong methodology studies of patients with gliomas. Exercise rehabilitation may maintain or even improve functional performance and QOL domains during medical treatment regimens. Functional independent patients with GBM are capable to comply with generic exercise recommendations and may be willing to participate in exercise rehabilitation if supervised by physical therapists.

Entities:  

Keywords:  Brain tumour; outpatient rehabilitation; physical therapy

Mesh:

Year:  2018        PMID: 29382243     DOI: 10.1080/09638288.2018.1432707

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  6 in total

1.  Breaking the patientification process - through co-creation of care, using old arctic survival knowledge.

Authors:  Ulrika Sandén; Lars Harrysson; Hans Thulesius; Fredrik Nilsson
Journal:  Int J Qual Stud Health Well-being       Date:  2021-12

2.  Feasibility, Safety and Effects of a One-Week, Ski-Based Exercise Intervention in Brain Tumor Patients and Their Relatives: A Pilot Study.

Authors:  Fabian M Troschel; Christian Ramroth; Lars Lemcke; Jens Clasing; Amelie S Troschel; Martin Dugas; Walter Stummer; Rainer Wiewrodt; Ralf Brandt; Dorothee Wiewrodt
Journal:  J Clin Med       Date:  2020-04-02       Impact factor: 4.241

3.  Finding 'the inner drive' for a rehabilitation process: a small-scale qualitative investigation among male patients with primary glioma.

Authors:  Mette Lysdahl Fahrenholtz; Anders Hansen; Karen Søgaard; Lotte Nygaard Andersen
Journal:  BMJ Open       Date:  2019-12-08       Impact factor: 2.692

Review 4.  Physical activity and exercise in adults diagnosed with primary brain cancer: a systematic review.

Authors:  Carolina X Sandler; Misa Matsuyama; Tamara L Jones; John Bashford; Danette Langbecker; Sandra C Hayes
Journal:  J Neurooncol       Date:  2021-04-28       Impact factor: 4.130

5.  The Impact of Resistance Exercise on Muscle Mass in Glioblastoma in Survivors (RESIST): Protocol for a Randomized Controlled Trial.

Authors:  Melanie R Keats; Scott A Grandy; Christopher Blanchard; Jonathon R Fowles; Heather F Neyedli; Adrienne C Weeks; Mary V MacNeil
Journal:  JMIR Res Protoc       Date:  2022-05-04

6.  Factors Influencing the Improvement of Activities of Daily Living during Inpatient Rehabilitation in Newly Diagnosed Patients with Glioblastoma Multiforme.

Authors:  Keisuke Natsume; Harutoshi Sakakima; Kentaro Kawamura; Akira Yoshida; Shintaro Akihiro; Hajime Yonezawa; Koji Yoshimoto; Megumi Shimodozono
Journal:  J Clin Med       Date:  2022-01-14       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.